The effect of cholecystokinin on postoperative bowel function.
Cholecystokinin (CCK) was used in a randomized double-blind trial to evaluate its effect on post-operative paralytic ileus. Sixty patients were admitted to the study. The return of postoperative intestinal motility was registered with subjective and/or objective methods. No differences were found between the CCK group and the placebo group.
D000328:Adult; D000368:Aged; D002763:Cholecystectomy; D002766:Cholecystokinin / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000601:surgery; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D011897:Random Allocation
D002766:Cholecystokinin